Mesenchymal Stem Cells Increase Expression of Heme Oxygenase-1 Leading to Anti-Inflammatory Activity in Treatment of Acute Liver Failure

Zhi-heng Zhang,Wei Zhu,Hao-zhen Ren,Xin Zhao,Shuai Wang,Hu-cheng Ma,Xiao-lei Shi
DOI: https://doi.org/10.1186/s13287-017-0524-3
2017-01-01
Stem Cell Research & Therapy
Abstract:Mesenchymal stem cells (MSCs) have been studied for the treatment of acute liver failure (ALF) for several years. MSCs may exert their effect via complex paracrine mechanisms. Heme oxygenase (HO) 1, a rate-limiting enzyme in heme metabolism, exerts a wide range of anti-inflammatory, anti-apoptotic and immunoregulatory effects in a variety of diseases. However, the relationship between MSCs and HO-1 in the treatment of ALF is still unclear. We investigated the preventive and therapeutic potential of intravenously administered BMSCs.
What problem does this paper attempt to address?